Speakers
Dr. Garth Powis D. Phil, Director, Professor & Director,
La Jolla CA, USA View Profile
Dr. Garth Powis
D. Phil, Director, Professor & Director,La Jolla CA, USA
Sanford Burnham Prebys NCI-Designated Cancer Center, Dr. Garth Powis, Director, Sanford Burnham Prebys NCI-Cancer Center, La Jolla, California, is a molecular and translational pharmacologist with more than 350 publications and 15 patents. His research focuses on the mechanisms that enable cancer cells to survive stress. Powis’ work has resulted in three novel cancer drugs currently in clinical trials. The expertise he brings to SBP encompasses all stages of cancer drug discovery and development, from early target identification to clinical studies with cancer patients. Dr. Powis trained at Oxford University before working at the Mayo Clinic, becoming deputy chair of Pharmacology; at University of Arizona Cancer Center as director of Basic Research; and most recently at MD Anderson Cancer Center, where he served as chair of Experimental Therapeutics and director of the Center for Targeted Therapy.
Dr. Jason Hipp MD, PhD, Lead Pathologist & Consultant,
Verily (Google), USA View Profile
Dr. Jason Hipp
MD, PhD, Lead Pathologist & Consultant,Verily (Google), USA
Medical Brain team, Dr. Jason Hipp is the lead pathologist and consultant at Google. He is a board certified pathologist and physician-scientist with expertise in Digital Pathology and developing pathology informatics tools for personalized medicine and companion diagnostics. He has a diverse research background, including over 47 publications on a variety of biomedical and technological issues, with a common theme of developing innovative approaches and methodologies for advancing regenerative medicine and cancer diagnostics. He is experienced in leveraging clinical training and consulting experiences to build multi-disciplinary teams to analyze and solve various technological, biological, and medical challenges.
Dr. Lynn Kirkpatrick PhD, CEO, Ensyce Biosciences San Diego,
CA, USA View Profile
Dr. Lynn Kirkpatrick
PhD, CEO, Ensyce Biosciences San Diego,CA, USA
Dr. D. Lynn Kirkpatrick, CEO, Ensyce Biosciences, La Jolla, California, has focused her entire career on cancer drug discovery and development. Former Professor of Chemistry and Biochemistry at the University of Regina, Canada, she has co-founded two start up companies and successfully brought three novel cancer drug candidates into human clinical trails. Following the acquisition of her first company, by Biomira Inc., (Oncothyreon) in 2006, Dr. Kirkpatrick took the role as the Chief Scientific Officer of the merged company. She became President and CEO of Ensysce Biosciences Inc. in January 2009. Dr. Kirkpatrick received her PhD from the University of Saskatchewan and completed a post-doctoral fellowship at Yale University School of Medicine. She has published extensively in the area of targeted cancer drug discovery and development and holds numerous patents for novel targeted cancer drugs.
Dr. Roy S Herbst MD, PhD, Chief of Medical Oncology, Yale Cancer Center & Smilow Cancer Hospital,
USA View Profile
Dr. Roy S Herbst
MD, PhD, Chief of Medical Oncology, Yale Cancer Center & Smilow Cancer Hospital,USA
Dr. Roy Herbst is recognized for his leadership and expertise in lung cancer treatment and research. He is best known for his work in developmental therapeutics and the personalized therapy of non-small cell lung cancer, in particular the process of linking genetic abnormalities of cancer cells to novel therapies. Prior to his appointment at Yale, Dr. Herbst was the Barnhart Distinguished Professor and Chief of the Section of Thoracic Medical Oncology in the Department of Thoracic/Head and Neck Medical Oncology, at The University of Texas M.D. Anderson Cancer Center (UT-MDACC) in Houston, Texas. He also served as Professor in the Department of Cancer Biology and Co-Director of the Phase I Clinical Trials Program. Dr. Herbst’s primary mission is the enhanced integration of clinical, laboratory, and research programs to bring new treatments to cancer patients. He has led the Phase I development of several of the new generation of targeted agents for non-small cell lung cancer (NSCLC), including gefitinib, erlotinib, cetuximab, and bevacizumab. More recently, he participated in the successful registration of pembrolizumab for the treatment of advanced non-small cell lung cancer, following the successful Yale-led KEYNOTE 10 study of the immune therapy drug commonly used to treat other cancers.
Dr. Stanley R. Hamilton MD, Head, Pathology & Laboratory Medicine, MD Anderson Cancer Center,
USA View Profile
Dr. Stanley R. Hamilton
MD, Head, Pathology & Laboratory Medicine, MD Anderson Cancer Center,USA
Dr. Stanley R. Hamilton is a gastrointestinal and molecular pathologist and Professor and Head of Pathology and Laboratory Medicine at The University of Texas M. D. Anderson Cancer Center since 1988. He has been active in the cooperative oncology group setting as a member of the Eastern Cooperative Oncology Group, now ECOG-ACRIN Cancer Research Group for more than two decades and has published studies of the molecular pathology of colorectal cancer using specimens from ECOG clinical trials. He is a member of the ECOG-ACRIN Disease Oriented Committee/Modality Oriented Committee (DOC/MOC) and the Leadership group. He continues to participate as pathologist for the Gastrointestinal Committee and has served since 1992 as Chair of the Laboratory Science and Pathology Committee that has responsibility for the earlier Pathology Coordinating Office and other core biorepositories, and is an ECOG-ACRIN representative on the NCI Group Banking Committee of ECOG-ACRIN. He is also a member of the Advisory Panel for the NCI Cooperative Group Banks Navigation System IT Project and the Principal Investigator for MD Anderson Cancer Center as a Scientific Member in ECOG-ACRIN. At MD Anderson, he has served as PI of the Cancer Center Support Grant-sponsored Tissue Biorepository and Pathology Resource core facility since 1998.
Prof. Syed Hussain CPeninsula Schools of Medicine and Dentistry,
UK View Profile
Prof. Syed Hussain
CPeninsula Schools of Medicine and Dentistry,UK
Dr. Raj Naik Northern Gynecological Oncology Centre, Queen Elizabeth Hospital, Gateshead,
UK View Profile
Dr. Raj Naik
Northern Gynecological Oncology Centre, Queen Elizabeth Hospital, Gateshead,UK
Prof. Tallal Younis Consultant Medical Oncologist, Professor of Medicine Dalhousie University,
Canada View Profile
Prof. Tallal Younis
Consultant Medical Oncologist, Professor of Medicine Dalhousie University,Canada
Dr. Saleh Al-Othman Deputy Executive Director, King Faisal Special Hospital & Research Centre,
KSA View Profile
Dr. Saleh Al-Othman
Deputy Executive Director, King Faisal Special Hospital & Research Centre,KSA
Dr. Hisham Shams Maher Chief Medical Officer, Al Borg Medical Laboratories,
Jeddah, KSA View Profile
Dr. Hisham Shams Maher
Chief Medical Officer, Al Borg Medical Laboratories,Jeddah, KSA
Dr. Rasha Kamal Professor of Radiology, Women's Imaging Unit, Faculty of Medicine, Cairo University,
Egypt View Profile
Dr. Rasha Kamal
Professor of Radiology, Women's Imaging Unit, Faculty of Medicine, Cairo University,Egypt
Prof. Fatma Al Mulhim Consultant Radiologist, Head of Breast Imaging Unit, KFUH,
KSA View Profile
Prof. Fatma Al Mulhim
Consultant Radiologist, Head of Breast Imaging Unit, KFUH,KSA
Chairperson of Breast Cancer Early Diagnostic Committee
Dr. Nivine Chalabi MD, Associate Professor, Radiology Dept. University of Ain Shams,
Egypt View Profile
Dr. Nivine Chalabi
MD, Associate Professor, Radiology Dept. University of Ain Shams,Egypt
Dr. Gaurav Kharya Oncology Immunology & BMT Artemis Hospital,
Gurgaon, India View Profile
Dr. Gaurav Kharya
Oncology Immunology & BMT Artemis Hospital,Gurgaon, India
Dr. Gaurav Kharya
Senior Consultant & Head Pediatric Hematology
Oncology Immunology & BMT Artemis Hospital
Gurgaon, India
Dr. Ridzuan Farouk National University of Singapore,
Singapore View Profile
Dr. Ridzuan Farouk
National University of Singapore,Singapore
Head of Colorectal Surgery,
National University Hospital,
Singapore
Dr. Dinesh Chinchure National University of Singapore,
Singapore View Profile
Dr. Dinesh Chinchure
National University of Singapore,Singapore
Consultant and Training Lead, Department of Diagnostic Radiology, Khoo Teck Puat Hospital, Singapore;
Clinical Senior Lecturer, National University of Singapore
NUS-YLL School of Medicine, Singapore
Dr. Saeeda Al-Marzooqi Tawam Hospital,
Abu Dhabi, UAE View Profile
Dr. Saeeda Al-Marzooqi
Tawam Hospital,Abu Dhabi, UAE
Asst. Professor, College of Medical Science, UAE University; Histopathologist
Dr. Zainul Aabideen Burjeel Hospital,
Abu Dhabi, UAE View Profile
Dr. Zainul Aabideen
Burjeel Hospital,Abu Dhabi, UAE
Dr. Zainul Aabideen
FRCPCH, CCT (UK), MSc Oncology
Consultant Pediatric Hematologist &
Oncologist, Burjeel Hospital
Abu Dhabi, UAE
Dr. Salem Awadh Advanced Center for Daycare Surgery,
Abu Dhabi, UAE View Profile
Dr. Salem Awadh
Advanced Center for Daycare Surgery,Abu Dhabi, UAE
Senior Physician & Gastroenterologist Hepatologist,
Dr. Martine McManus Cleveland Clinic,
Abu Dhabi, UAE View Profile
Dr. Martine McManus
Cleveland Clinic,Abu Dhabi, UAE
Consultant Pathologist,
Dr. Makki Fayadh Advanced Center for Daycare Surgery,
Abu Dhabi, UAE View Profile
Dr. Makki Fayadh
Advanced Center for Daycare Surgery,Abu Dhabi, UAE
Consultant Physician & Gastroenterologist,
